Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop its novel ...

Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

Asthma remains one of the most prevalent chronic diseases in the US. 3 Although poor adherence substantially contributes to inadequate outcomes, even patients with high adherence often experience ...

Dr. Marc Cromie with the Chattanooga Allergy Clinic joins News 12’s Chip Chapman at the start of the New Year with some ...

Objective Anxiety affects up to one-third of adults with asthma and is linked to poorer disease outcomes and reduced quality ...

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple ...

Please provide your email address to receive an email when new articles are posted on . Global Initiative for Asthma (GINA) guidelines recommend single maintenance and reliever therapy (SMART) for ...

Statins were linked to decreased risk for acute asthma exacerbations in mild asthma and had a significant protective effect in Black patients.

IN 2010 AN American girl called Emily Whitehead developed a form of leukaemia that is usually terminal. She was five years old. Two years later, she became the first paediatric patient to be offered a ...

Please provide your email address to receive an email when new articles are posted on . Nearly half of surveyed primary care physicians reported unawareness of biologics for asthma. A majority of ...